Literature DB >> 15647351

Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors.

Bryan A Ballif1, Philippe P Roux, Scott A Gerber, Jeffrey P MacKeigan, John Blenis, Steven P Gygi.   

Abstract

Reversible protein phosphorylation is an essential cellular regulatory mechanism. Many proteins integrate and are modulated by multiple phosphorylation events derived from complex signaling cues. Simultaneous detection and quantification of temporal changes in all of a protein's phosphorylation sites could provide not only an immediate assessment of a known biochemical activity but also important insights into molecular signaling mechanisms. Here we show the use of stable isotope-based quantitative MS to globally monitor the kinetics of complex, ordered phosphorylation events on protein players in the canonical mitogen-activated protein kinase signaling pathway. In excellent agreement with activity assays and phosphospecific immunoblotting with the same samples, we quantified epidermal growth factor-induced changes in nine phosphorylation sites in the extracellular signal-regulated kinase (ERK)/p90 ribosomal S6 kinase-signaling cassette. Additionally, we monitored 14 previously uncharacterized and six known phosphorylation events after phorbol ester stimulation in the ERK/p90 ribosomal S6 kinase-signaling targets, the tuberous sclerosis complex (TSC) tumor suppressors TSC1 and TSC2. By using quantitative phosphorylation profiling in conjunction with pharmacological kinase inhibitors we uncovered a ERK-independent, protein kinase C-dependent pathway to TSC2 phosphorylation. These results establish quantitative phosphorylation profiling as a means to simultaneously identify, quantify, and delineate the kinetic changes of ordered phosphorylation events on a given protein and defines parameters for the rapid discovery of important in vivo phosphoregulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647351      PMCID: PMC545566          DOI: 10.1073/pnas.0409143102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS.

Authors:  Scott A Gerber; John Rush; Olaf Stemman; Marc W Kirschner; Steven P Gygi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-27       Impact factor: 11.205

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  Phosphoproteomic analysis of the developing mouse brain.

Authors:  Bryan A Ballif; Judit Villén; Sean A Beausoleil; Daniel Schwartz; Steven P Gygi
Journal:  Mol Cell Proteomics       Date:  2004-09-02       Impact factor: 5.911

4.  A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture.

Authors:  Nieves Ibarrola; Dario E Kalume; Mads Gronborg; Akiko Iwahori; Akhilesh Pandey
Journal:  Anal Chem       Date:  2003-11-15       Impact factor: 6.986

5.  Site-specific mass tagging with stable isotopes in proteins for accurate and efficient protein identification.

Authors:  X Chen; L M Smith; E M Bradbury
Journal:  Anal Chem       Date:  2000-03-15       Impact factor: 6.986

6.  Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.

Authors:  Philippe P Roux; Stephanie A Richards; John Blenis
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

Review 7.  United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling.

Authors:  B D Manning; L C Cantley
Journal:  Biochem Soc Trans       Date:  2003-06       Impact factor: 5.407

8.  Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.

Authors:  Michael N Corradetti; Ken Inoki; Nabeel Bardeesy; Ronald A DePinho; Kun-Liang Guan
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

9.  Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.

Authors:  Shao-En Ong; Blagoy Blagoev; Irina Kratchmarova; Dan Bach Kristensen; Hanno Steen; Akhilesh Pandey; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2002-05       Impact factor: 5.911

10.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.

Authors:  Andrew R Tee; Diane C Fingar; Brendan D Manning; David J Kwiatkowski; Lewis C Cantley; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

View more
  82 in total

1.  ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1).

Authors:  Audrey Carriere; Yves Romeo; Hugo A Acosta-Jaquez; Julie Moreau; Eric Bonneil; Pierre Thibault; Diane C Fingar; Philippe P Roux
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

2.  Fyn promotes phosphorylation of collapsin response mediator protein 1 at tyrosine 504, a novel, isoform-specific regulatory site.

Authors:  Gwen R Buel; John Rush; Bryan A Ballif
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

Review 3.  Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway.

Authors:  Jaroslaw Jozwiak; Sergiusz Jozwiak; Tomasz Grzela; Maciej Lazarczyk
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  Methodologies for characterizing phosphoproteins by mass spectrometry.

Authors:  Philip R Gafken; Paul D Lampe
Journal:  Cell Commun Adhes       Date:  2006 Sep-Dec

5.  Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry.

Authors:  Pedro R Cutillas; Asim Khwaja; Mariona Graupera; Wayne Pearce; Severine Gharbi; Mike Waterfield; Bart Vanhaesebroeck
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

6.  The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.

Authors:  T R Hartman; E Nicolas; A Klein-Szanto; T Al-Saleem; T P Cash; M C Simon; E P Henske
Journal:  Oncogene       Date:  2009-02-23       Impact factor: 9.867

7.  PKC induces release of a functional ectodomain of the guidance cue semaphorin6A.

Authors:  Riley M St Clair; Caroline M Dumas; Kori S Williams; Matthew T Goldstein; Elizabeth A Stant; Alicia M Ebert; Bryan A Ballif
Journal:  FEBS Lett       Date:  2019-08-16       Impact factor: 4.124

8.  Quantitative analysis of complex peptide mixtures using FTMS and differential mass spectrometry.

Authors:  Fanyu Meng; Matthew C Wiener; Jeffrey R Sachs; Chrissina Burns; Priyanka Verma; Cloud P Paweletz; Matthew T Mazur; Ekaterina G Deyanova; Nathan A Yates; Ronald C Hendrickson
Journal:  J Am Soc Mass Spectrom       Date:  2006-10-25       Impact factor: 3.109

9.  Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Authors:  Mark Rolfe; Laura E McLeod; Phillip F Pratt; Christopher G Proud
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

10.  Mammalian target of rapamycin complex 1 (mTORC1) plays a role in Pasteurella multocida toxin (PMT)-induced protein synthesis and proliferation in Swiss 3T3 cells.

Authors:  Hammou Oubrahim; Allison Wong; Brenda A Wilson; P Boon Chock
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.